DTC
VERA icon

Deep Track Capital’s Vera Therapeutics VERA Stock Holding History

Deep Track Capital’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$165M Buy
4,106,067
+1,284,932
+46% +$55.4M 2.7% 10
2025
Q4 		$143M Buy
+2,821,135
New +$100M 2.55% 12

Other funds holding VERA

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Deep Track Capital's VERA Position: Q1 2026 in Review

Deep Track Capital increased its Vera Therapeutics (VERA) stake by 46% in Q1 2026, buying an estimated $55.4M and bringing the position to 4,106,067 shares worth $165M. The position accounts for 2.7% of the portfolio, ranked #10.

Deep Track Capital first reported a position in VERA in Q4 2025 and has held it in 2 quarters since. 229 funds tracked by Wall St. Rank hold VERA as of Q1 2026.

  • Deep Track Capital held 4,106,067 shares of Vera Therapeutics worth $165M as of Q1 2026.
  • Deep Track Capital bought 1,284,932 Vera Therapeutics shares in Q1 2026, an estimated $55.4M.
  • Vera Therapeutics made up 2.7% of Deep Track Capital's portfolio in Q1 2026, its #10 holding.
  • Deep Track Capital first reported a position in Vera Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • 229 funds tracked by Wall St. Rank held Vera Therapeutics as of Q1 2026.

Based on Deep Track Capital's 13F filing for Q1 2026, filed 15 May 2026.